FIELD: chemistry.
SUBSTANCE: present invention pertains to novel pyrrolo[3,2-b]pyridine derivatives of formula I 
, where values of radicals R1-R5 are given in the description. The invention also covers pharmaceutically acceptable salts of these compounds, methods of producing these compounds and pharmaceutical compositions containing these compounds. Pyrrolo[3,2-b]pyridine derivatives and their pharmaceutically acceptable salts can provide proton pump reversible inhibitory effect.
EFFECT: obtaining novel pharmaceutically acceptable salts which can provide proton pump reversible inhibitory effect.
5 cl, 2 tbl, 289 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND METHODS FOR MAKING THEREOF | 2005 |
|
RU2375359C2 |
| PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2378275C2 |
| PYRROLO[2,3-c]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2385320C2 |
| GPR40 RECEPTOR AGONIST, METHODS OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT | 2013 |
|
RU2650506C2 |
| TETRAHYDROCARBOLINE DERIVATIVE | 2011 |
|
RU2572818C2 |
| SUBSTITUTED HYDRATED TIENO-PYRROLO [3,2-c] PYRIDINES, LIGANDS, PHARMACEUTICAL COMPOSITION AND ITS APPLICATION METHOD | 2010 |
|
RU2451686C1 |
| NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF | 2014 |
|
RU2621709C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| PYRROLO[3,2-B]PYRIDINE DERIVATIVE USEFUL AS A MUSCARINE ACETYLCHOLINE RECEPTOR MODULATOR (mAChR)M1 (mAChR M1) | 2014 |
|
RU2688938C2 |
| TRICYCLIC PYRROLE DERIVATIVES USEFUL AS 5-HT RECEPTOR MODULATORS | 2010 |
|
RU2567751C2 |
